Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney
  • Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease

    Annals of Internal Medicine Date published:
  • Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study

    BMC Nephrology Date published:
  • Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial

    Journal of Renal Nutrition Date published:
  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    New England Journal of Medicine Date published:
  • Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial

    Nephrology Date published:
  • Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units

    Nephrology Date published:
  • Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis

    Nephrology Date published:
  • Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

    BMC Cardiovascular Disorders Date published:
  • The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study

    Quality of Life Research Date published:
  • Effect of extended hours dialysis on sleep quality in a randomized trial

    Nephrology Date published:
  • Cardiovascular adaptations associated with exercise in patients on hemodialysis

    Seminars in Dialysis Date published:
  • Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

    PLoS ONE Date published:
  • Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:
  • Burden of Care and Quality of Life Among Caregivers for Adults Receiving Maintenance Dialysis: A Systematic Review

    American Journal of Kidney Diseases Date published:
  • Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

    BMJ Open Date published:
  • Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort

    Canadian Journal of Kidney Health and Disease Date published: